Chongqing Pharscin Pharmaceutical Co.,Ltd.’s Net Profit Rose 7.2% in 2022

Chongqing Pharscin Pharmaceutical Co.,Ltd. (重庆华森制药股份有限公司) (002907.SZ) reported a net profit of 98.4 million yuan in 2022, up 7.2% year-on-year.

Meanwhile, the company posted 785.2 million yuan in revenue, down 7.2% year-on-year.

At the end of the reporting period, it had 1.9 billion yuan in total assets and 256.3 million yuan in total liabilities, with a liability-to-asset ratio of 13.7%.